摘要
目的比较miR-1过表达及表达抑制后人宫颈癌细胞HPV16+Siha以及HPV18+Hela中细胞周期蛋白的表达影响,了解miR-1在HR HPV致瘤过程中的分子机制。方法构建miR-1过表达慢病毒载体及miR-1缺陷表达载体,转染高危型(HR) HPV16+/18+人宫颈癌细胞,运用Western blot方法对各组转染细胞中细胞周期蛋白Cyclin D1、Cyclin D2、Cyclin E的表达进行检测。结果 (1)成功获得miR-1过表达及表达抑制的人宫颈癌细胞株Hela和Siha;(2)与空白对照组相比,miR-1过表达及表达抑制后HR HPV16+/18+人宫颈癌细胞株中细胞周期蛋白出现了相应的表达改变。结论 miR-1在HR HPV+人宫颈癌中的致瘤性与其对细胞周期蛋白的表达调控密切相关。
Objective To explore the expressional changes of cell-cycle associated proteins,Cyclin D1,Cyclin D2 and Cyclin E,in high-risk(HR)human papillomavirus(HPV)infected(+)cervical cancer cells following miR-1 overexpression or inhibition.Method The lentiviral system and specific sponge target miR-1 were used to up-regulate or inhibit the expression of miR-1 in HR HPV16+Siha and HPV18+Hela cells.Western bot was employed to determine the expressional changes of Cyclin D1,Cyclin D2 and Cyclin E amang those differently treated cell lines.Results The expression of miR-1 in HR HPV16+Siha and HPV18+Hela cells were significantly up-regulated or inhibited after lentiviral system or sponge transfection.Western blot analysis revealed that the relative expressions of Cyclin D1,Cyclin D2 and Cyclin E in HR HPV+Hela/Siha cells were altered,following miR-1 overexpression or inhibition.Conclusion The expressional changes of various cell cycle related proteins were associated with the oncogenesis events of miR-1 in HR HPV infected cervical cancer cells.
作者
胡滔
洪颖
陈红兰
常业飞
姜水
习杨彦彬
檀雅欣
李珊
刘光彩
吴晓虹
HU Tao;HONG Ying;CHEN Hong-lan;CHANG Ye-Fei;JIANG Shui;XIYANG Yan-bin;TAN Ya-xin;LI Shan;LIU Guang-cai;WU Xiao-hong(Department of Laboratory Medicine,The Third People's Hospital of Yunnan Province,Kunming Yunnan 650011;Basic Medical College,Kunming Medical University;Physical Education Department,Kunming Medical University,Kunming Yunnan 650500,China)
出处
《昆明医科大学学报》
CAS
2018年第12期11-15,共5页
Journal of Kunming Medical University
基金
国家自然科学基金资助项目(81502377)
云南省高层次卫生计生技术人才培养专项基金资助项目(H-2017026)
云南省应用基础研究计划基金资助项目(2016FB139)
关键词
宫颈癌
高危型人乳头瘤病毒16/18型
MIR-1
细胞周期蛋白
Cervical cancer
High-risk human papillomavirus(HR HPV)16/18 infection
G6PD
miR-1
Cell cycle associated proteins